Stallion India Fluorochemicals Reaffirms FY26 Revenue Growth Target
Filing Summary
Stallion India Fluorochemicals Limited has reaffirmed its revenue growth guidance of 30-35% for FY26. The company has utilized funds from a promoter’s stake sale to purchase additional land and appoint EPC contractors for its R-32 project in Bhilwara. The project is on track for commercial commencement by July 2026. The funds have been deployed interest-free for expansion activities, including site development and technology acquisition. The company has received advance order bookings, indicating strong customer confidence. The R-32 plant is projected to generate ₹500 crore in annual revenue.
Stallion India Fluorochemicals Limited has reaffirmed its revenue growth guidance of 30-35% for the fiscal year 2026. The announcement was made on 24th November 2025, highlighting the company’s operational updates and future plans. The company has focused on expanding its operations and enhancing its project execution capabilities.
The company has utilized funds received from a small sale of the promoter’s stake. These funds have been introduced interest-free into the company. The financial resources have been allocated for purchasing additional land adjacent to the current site, appointing EPC contractors, and acquiring process technology. The funds have also been used for pre-construction work and placing orders for plant and machinery with advances.
The scope of the company’s current expansion includes the R-32 project in Bhilwara. This project involves the construction of a new plant, which is expected to commence commercial operations by July 2026. The environmental and regulatory clearances are anticipated to be completed shortly, allowing full-scale work to begin. The company has entered into agreements for technology transfer and has started site development and civil work.
The company has reported receiving advance order bookings and contracts for supply from large buyers. This indicates strong customer confidence and visibility in future demand. The R-32 plant is projected to generate around ₹500 crore in annual revenue with PAT margins in the range of 22%. This positions the company for sustained profitability in the refrigerants and industrial gases segment.
The timeline for the R-32 project includes the completion of environmental and regulatory clearances, followed by the commencement of full-scale construction activities. The project is scheduled for commercial commencement by July 2026. The funds from the promoter’s stake sale have been entirely deployed towards these expansion activities, reflecting the promoters’ commitment to project execution.
Stallion India Fluorochemicals Limited is a specialized leader in the refrigerants and industrial gases sector. The company focuses on processing, blending, and distributing gases across various industries, including air conditioning, refrigeration, and pharmaceuticals. With strategic manufacturing facilities, the company differentiates itself through its focus on gas blending, setting it apart from competitors who primarily manufacture base molecules.